Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol

The objectives of this study were to characterize any drug-drug interaction between the antimalarial Pyramax (pyronaridine-artesunate [PA]) and the CYP2D6 probe substrate metoprolol and to assess the safety of 60-day or 90-day PA redosing, particularly with regard to liver biochemistry parameters. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Carrie A., Pokorny, Rolf, Lopez-Lazaro, Luis, Miller, Robert M., Arbe-Barnes, Sarah, Duparc, Stephan, Borghini-Fuhrer, Isabelle, Shin, Jang-Sik, Fleckenstein, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2014
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187956/
https://www.ncbi.nlm.nih.gov/pubmed/25070091
http://dx.doi.org/10.1128/AAC.02716-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187956/
https://www.ncbi.nlm.nih.gov/pubmed/25070091
http://dx.doi.org/10.1128/AAC.02716-14

Ejemplares similares